Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Gynecologic Oncology|February 28, 2024
Laparoscopic predictability of minimally invasive interval debulking in advanced ovarian cancer: The MIID-SOC trialAnthony B Costales, Erin K Crane, Laura Chambers, et al.
Gynecologic Oncology|July 7, 2020
A guide to establishing a hyperthermic intraperitoneal chemotherapy program in gynecologic oncologyLaura M Chambers, Anthony B Costales, Katie Crean-Tate, et al.
Blood|February 10, 2007
Abnormal activation and cytokine spectra in lymph nodes of people chronically infected with HIV-1Angélique Biancotto, Jean-Charles Grivel, Sarah J Iglehart, et al.
Frontiers in Oncology|February 27, 2024
Carboplatin, paclitaxel, and pembrolizumab followed by pembrolizumab maintenance for primary treatment of incompletely resected epithelial ovarian cancerDenise Uyar, Chad M Michener, Erin Bishop, et al.
NPJ Precision Oncology|September 12, 2018
Case study: patient-derived clear cell adenocarcinoma xenograft model longitudinally predicts treatment responseRoberto Vargas, Priyanka Gopal, Gwendolyn B Kuzmishin, et al.
Surgical Endoscopy|August 28, 2023
Physiologic tension of the abdominal wallBenjamin T Miller, Ryan C Ellis, R Matthew Walsh, et al.
Gynecologic Oncology|June 4, 2021
Modified frailty index predicts postoperative complications in women with gynecologic cancer undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapyLaura M Chambers, Julia Chalif, Meng Yao, et al.
Journal of Ovarian Research|April 23, 2021
Pretreatment with LCK inhibitors chemosensitizes cisplatin-resistant endometrioid ovarian tumorsKatie K Crean-Tate, Chad Braley, Goutam Dey, et al.
Plos One|February 26, 2013
Interferon-α is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markersGareth A D Hardy, Scott Sieg, Benigno Rodriguez, et al.
Gynecologic Oncology|July 7, 2023
A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283Roisin E O'Cearbhaill, Austin Miller, Robert A Soslow, et al.
Pageof 7